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Gram-negative bacterial lipopolysaccharide (LPS) induces a pathologic increase
in lung vascular leakage under septic conditions. LPS-induced human pulmonary
micro-vascular endothelial cell (HPMEC) apoptosis launches and aggravates
micro-vascular hyper-permeability and acute lung injury (ALI). Previous studies
show that the activation of intrinsic apoptotic pathway is vital for LPS-induced EC
apoptosis. Yes-associated protein (YAP) has been reported to positively regulate intrinsic
apoptotic pathway in tumor cells apoptosis. However, the potential role of YAP protein
in LPS-induced HPMEC apoptosis has not been determined. In this study, we found
that LPS-induced activation and nuclear accumulation of YAP accelerated HPMECs
apoptosis. LPS-induced YAP translocation from cytoplasm to nucleus by the increased
phosphorylation on Y357 resulted in the interaction between YAP and transcription
factor P73. Furthermore, inhibition of YAP by small interfering RNA (siRNA) not only
suppressed the LPS-induced HPMEC apoptosis but also regulated P73-mediated
up-regulation of BAX and down-regulation of BCL-2. Taken together, our results
demonstrated that activation of the YAP/P73/(BAX and BCL-2)/caspase-3 signaling
pathway played a critical role in LPS-induced HPMEC apoptosis. Inhibition of the YAP
might be a potential therapeutic strategy for lung injury under sepsis.
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INTRODUCTION
Sepsis is a serious consequence of Gram-negative bacterial infection in critically ill patients (Wendel
et al., 2007). Under septic condition, the most frequently affected tissue is the endothelium lining
the intimal surface of the vasculature (Cook-Mills and Deem, 2005). Lipopolysaccharide (LPS),
as a major component of the outer membrane of Gram-negative bacteria, induces a multitude
of endothelial dysfunctions, such as the coagulation activation and vascular barrier disruption
(Zhou et al., 2013; Yi et al., 2016). Furthermore, LPS-induced endothelial cells (ECs) apoptosis
and detachment from the vessel basement membrane deteriorates LPS-induced micro-vascular
injury and further induces dysfunction in multiple organs (Hotchkiss et al., 2002). Recent studies
have showed that the sepsis-induced acute lung injury (ALI) is characterized by apoptosis of the
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lung micro-vascular endothelial cells (Gill et al., 2014, 2015).
However, the signaling transduction pathways implicated in
LPS-induced human pulmonary micro-vascular endothelial cell
(HPMEC) apoptosis remains unclear. In this study, we aim to
define the molecular mechanism by which LPS induces apoptosis
of HPMECs in vitro.
Yes-associated protein (YAP) is a key effector of the
Hippo signaling pathway and is primarily inactivated by large
tumor suppressor gene (LATS) in the cytoplasm via serine
phosphorylation (Yu and Guan, 2013; Guo and Teng, 2015).
YAP protein is also a crucial transcriptional co-activator
and is involved in the regulation of cellular proliferation,
differentiation, transformation and apoptosis (Wang et al., 2014;
Hansen et al., 2015). When activated, YAP translocates from
the cytoplasm to the nucleus of cells and binds to downstream
transcription factors to regulate different biological functions
(Strano et al., 2001; Vassilev et al., 2001; Komuro et al.,
2003). Previous studies have reported that YAP is extensively
activated and mediates tumor cell apoptosis in response to DNA
damage (Zagurovskaya et al., 2009). However, whether YAP
is implicated in LPS-induced HPMEC apoptosis has not been
investigated.
To date, various transcription factors have been reported
to be the YAP target proteins, such as TEAD, P73, Egr-1,
Runx2, and ErbB-4 (Strano et al., 2001; Vassilev et al., 2001;
Komuro et al., 2003; Zagurovskaya et al., 2009). P73 displays
higher affinities for YAP and are positively regulated by YAP in
tumor cell apoptosis (Strano et al., 2005). The phosphorylation
of YAP on tyrosine 357 (T357) results in stabilization of
YAP protein, which promotes interaction between YAP and
P73 and further co-activates P73 downstream target genes
(Levy et al., 2008). However, the interaction between YAP
and P73 during LPS-induced HPMEC apoptosis has not been
investigated.
The BCL-2 family is characterized by the BCL-2 homology
domain, which mediates cellular apoptosis by regulating
mitochondrial membrane permeability (Youle and Strasser,
2008). P73-mediated regulation of BCL-2 family proteins
involves mechanisms related to many cells apoptosis (Tiwary
et al., 2011). Therefore, we hypothesized that YAP was involved
in LPS-induced HPMEC apoptosis via the activation of P73 and
the subsequent regulation of BCL-2 family proteins.
In the present study, we found that YAP was activated during
LPS-induced HPMEC apoptosis via the phosphorylation on
Y357, which accumulated in the nucleus and bound transcription
factor P73. Moreover, inhibition of YAP not only prevented EC
apoptosis induced by LPS but also blocked the activation of P73
in LPS-stimulated HPMEs. Our results first reported the core
effects of YAP/P73 signaling in LPS-induced HPMEC apoptosis,
which might play an important pathogenic role in sepsis-induced
lung injury.
MATERIALS AND METHODS
Cell Culture and Reagents
Primary HPMECs were obtained from ScienCell Research
Laboratories and were maintained in ScienCell Endothelial
Cell Medium in a humidified incubator at 37◦C with 5%
CO2. LPS (from Escherichia coli 055:B5) and cycloheximide
(CHX) were purchased from Sigma-Aldrich (St Louis, MO).
The anti-YAP rabbit monoclonal antibody and the anti-YAP
(phospho-Y357) rabbit polyclonal antibody were obtained
from ABCAM. The anti-BAX rabbit mAb, anti-BCL-2
rabbit mAb, anti-P73 mouse mAb, anti-cleaved caspase-3
rabbit mAb, anti-cleaved-PARP rabbit mAb and anti-rabbit
immunoglobulin-G-HRP-linked antibody were purchased from
Cell Signaling Technologies (Danvers, Mass). The anti-mouse
immunoglobulin-G-HRP-linked antibody, anti-pro-caspase-3
mouse mAb, anti-PARP mouse mAb and P73 siRNA (h):(sc-
36167) were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Control siRNA and YAP siRNA were synthesized
by GenePharma Co, Ltd. (Shanghai, China). Alexa Fluor
568-labeled donkey anti-rabbit secondary antibody, Pro-Long
Gold Antifade Mountant with DAPI and Lipofectamine
RNA-iMAX were obtained from Invitrogen Life Science.
The Annexin-V-FITC apoptosis kit was purchased from BD
Biosciences.
Cell Viability Assay
The Cell Counting Kit-8 (CCK-8; CK04, DOJINDO) was used to
assess cell viability according to themanufacturer’s protocol. Cells
were seeded in 96-well plates and cultured for 24–48 h. When the
monolayer of cells was 90% confluent, theHPMECswere exposed
to various concentrations of LPS or CHX for 24 h. Next, 10µl
of CCK-8 solution was added to each well, and the cells were
incubated for an additional 4 h. The absorbance at 450 nm was
measured using a micro-plate reader. The cell survival rate was
calculated using the average of pooled data from three separate
experiments of six wells.
Cell Apoptosis Analysis
HPMECs were treated separately with medium, LPS, CHX and
both LPS and CHX for 24 h with or without pretreatment with
special siRNA. The cells were then washed twice with pre-chilled
PBS and re-suspended in 1× binding buffer. HPMEC apoptosis
was quantified by staining with 5µl of Annexin V-fluorescein
isothiocyanate (FITC) and 5µl of PI. After incubation with
Annexin V/PI for 10 min in the dark, 300µl of 1× binding
buffer was added to the samples followed by flow cytometry
analysis.
Western Blot Analysis
Total protein was extracted from the HPMEC monolayers, and
protein expression was analyzed byWestern blotting. The protein
samples from the HPMEC lysates were separated by 6–12%
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) according to the molecular weight of the target proteins
and then electro-transferred to a PVDF membrane. The
membranes were blocked with Tris-buffered saline (TBS) and
Tween-20 containing 5% nonfat milk at room temperature
for 1 h and then incubated with antibodies against the target
proteins (diluted 1:1000) overnight at 4◦C. The membranes were
incubated with the appropriate HRP-linked secondary antibodies
(1:2000) at room temperature for 1 h. The signal intensities
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were compensated using β-actin or glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as internal controls. Finally, the bands
were developed with Western blot luminal reagent (Millipore,
Billerica, MA).
Immunoprecipitation
To verify the complex formation between P-YAP (Y357) and
P73 protein, HPMECs were lysed in 100µl of RIPA+PMSF
(1:100) containing protease inhibitor cocktail (1:100). The EC
extracts were incubated overnight with P73 antibody (diluted
1:100), followed by incubation for 2 h with 30µl of protein
A agarose beads (Santa Cruz Biotechnology) according to the
manufacturer’s protocol. The precipitates were washed three
times with lysis buffer on ice and then probed with anti-phospho-
YAP (Y357) antibody (diluted 1:1000) by Western blot.
Transfection with siRNA In vitro
YAP siRNA and P73 siRNA were transfected into HPMECs
at an optimal concentration using Lipofectamine RNA-iMAX
according to the manufacturer’s instructions. Duplex siRNA
was constructed against sequences encoding YAP positions (5′-
CUG CCA CCA AGC UAG AUA ATT -3′ and 5′-UUA UCU
AGC UUG GUG GCA GTT -3′). A scrambled negative control
siRNA (5′-UUC UCC GAA CGU GUC ACG UTT-3′ and 5′-
ACG UGA CAC GUU CGG AGA ATT-3′) was also included.
P73 siRNA (h) is a target-specific 19–25-nt siRNA that is
designed to knockdown P73 gene expression. The ability of
the RNA interference molecules to knockdown target proteins
expression was analyzed by Western blot analysis at 72 h after
transfection. Transfection of the FITC-labeled nonspecific siRNA
demonstrated that the transfection efficiency reached 85% in
HPMECs.
Immunofluorescent and
Immunocytochemical Staining
For P-YAP (Y357) protein staining, HPMECs were grown to
a density of 90% in Millicell EZ SLIDE 8-well glass plates
(Millipore NO.PEZGS0816) and treated with LPS (1µg/ml) and
CHX (10µg/ml) for 24 h. The monolayers were fixed with 4%
paraformaldehyde for 30min, washed, and blocked in phosphate-
buffered saline containing 10% bovine serum albumin and
0.1% Triton X-100 for 30 min. The monolayers were incubated
with anti-YAP (phospho-Y357) rabbit polyclonal antibody
(1:200) overnight at 4◦C, followed by Alexa Fluor 568-labeled
donkey anti-rabbit secondary antibody (1:250) for 1 h. Before
immunofluorescence analysis, anti-fade mountant containing
DAPI was added to the samples, and the fluorescence images
of P-YAP (Y357) mounted on glass coverslips were captured
by microscopy (Nikon, Tokyo, Japan). Immunocytochemical
staining of P-YAP (Y357) was visualized using the DAB system
according to the manufacturer’s instructions.
Statistical Analysis
All results are expressed as the means ± SEM of at least
3 independent experiments. Differences between groups were
compared using the t-test and one-way ANOVA with Bonferoni
post-hot analysis. Differences were considered significant at
P < 0.05.
RESULTS
CHX Is Required for LPS-Induced HPMEC
Apoptosis In vitro
HPMECs were stimulated with different concentrations of LPS
(0–100µg/ml) for 24 h. The survival rate of the ECs was detected
using CCK-8 (Figure 1A). Incubation with LPS alone did not
induce HPMEC death. Subsequently, HPMECs were incubated
with LPS and CHX simultaneously at various concentrations
(LPS at 0–1µg/ml and CHX at 0–20µg/ml). After 24 h, the
CCK-8 analysis revealed that the combination of LPS and CHX
decreased the survival rate of HPMECs. In contrast to using
CHX alone, the decrease in EC survival rate caused by the
combination of LPS and CHX peaked at 10µg/ml of CHX
(Figure 1B). We further used an Annexin-V/PI apoptosis kit
to quantify the numbers of apoptotic HPMECs. Both the total
apoptosis rate and early apoptosis rate reached a maximum
at 10µg/ml of CHX and 1µg/ml of LPS compared with the
control group after 24 h (Figures 1C–H). The combination
of LPS and CHX, but not LPS or CHX alone, induced
HPMEC apoptosis (Figures 1I–K). These data were further
confirmed by immunoblotting analysis of cleaved caspase-3
(Figures 1L,M).
YAP Is Activated via Phosphorylation of
Yap on Y357 during LPS-Induced HPMEC
Apoptosis
We further investigated the expression of YAP during LPS plus
CHX-induced HPMEC apoptosis. After incubating HPMECs
with LPS and CHX for 24 h, the expression of total YAP
and the phosphorylation of YAP on Y357 were evaluated
by Western blotting (Figure 2A). The data revealed no
significant differences among the groups in total YAP expression.
However, the combination of LPS and CHX significantly
increased P-YAP (Y357) expression when compared with
the medium, LPS or CHX groups alone (Figure 2B). These
results were further confirmed by immunocytochemical and
immunofluorescent staining for P-YAP (Y357) protein in
HPMEC. We found that the phosphorylation of Y357 in YAP
(colored red in the immunofluorescence images and brown
in the immunocytochemistry images) primarily occurred and
accumulated in HPMEC nuclei after stimulation with LPS and
CHX (Figure 2C).
Inhibition of YAP Protein Attenuated
LPS-Induced HPMEC Apoptosis
To investigate whether YAP was involved in the combined
LPS and CHX-induced EC apoptosis, we examined HPMECs
transfected with YAP siRNA. The effect of YAP knockdown
was confirmed by Western blot analysis (Figures 3A,B).
Flow cytometry demonstrated that combined LPS and
CHX-induced HPMEC apoptosis was blocked by YAP
siRNA at the indicated times (Figures 3C–E). PARP is
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FIGURE 1 | LPS induces HPMEC apoptosis in the presence of CHX. The viability of HPMECs was assessed after incubation with different concentrations of LPS
(0, 0.01, 0.1, 1, 10, 100µg/ml) for 24 h (A). HPMECs were further incubated with different concentrations of LPS (0, 0.1, 1µg/ml) and CHX (0–20µg/ml) for 24 h, and
(Continued)
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FIGURE 1 | Continued
viability was determined using the CCK-8 assay. When concentration of CHX was 10 µg/ml, the combination of LPS and CHX induced obvious cells death
(B). #P < 0.05 vs. the comparator group without LPS treatment. HPMECs were exposed to CHX (10µg/ml) and different concentration of LPS (0, 0.01, 0.1, 1, 10,
100µg/ml) for 24 h, and apoptosis was measured by Annexin V/PI staining. The total apoptosis rate is expressed as the sum of the right upper and right lower
quadrants. The early apoptosis rate is expressed as the right lower quadrants. The peak of apoptosis occurred at a LPS concentration of 1µg/ml (C). The results are
presented as a histogram showing the percentage of total apoptosis cells and early apoptosis cells (D,E). #P < 0.05 vs. the comparator group treated only with
CHX. HPMECs were incubated with CHX (10µg/ml) and LPS (1µg/ml) for the indicated times, and the apoptosis rate peaked at 24 h (F). The results are presented as
a histogram showing the percentage of total apoptosis cells and early apoptosis cells (G,H). *P < 0.05 vs. the control group. The combination of LPS (1µg/ml) and
CHX (10µg/ml), but not LPS or CHX alone, induced obvious HPMEC apoptosis after 24 h flow cytometry (I). The results are presented as a histogram showing the
percentage of total apoptosis cells and early apoptosis cells (J,K). *P < 0.05 vs. the control group. Cleaved caspase-3 expression was detected in HPMECs incubated
with LPS (1µg/ml) and CHX (10µg/ml) for 24 h (L,M). Cells treated with medium alone were used as a negative control. *P < 0.05 vs. the negative control group.
associated with DNA repair and is a significant marker of
apoptosis (Jemal et al., 2011). The above result was further
confirmed by Western blot analysis of cleaved PARP expression
(Figures 3F,G).
YAP Interacts with Transcription Factor
P73 during LPS-Induced HPMEC Apoptosis
To confirm whether YAP protein was involved in LPS plus
CHX-induced HPMEC apoptosis via the interaction with P73,
co-immunoprecipitation was used to verify the relationship
between P-YAP (Y357) and P73. The stimulation of LPS
and CHX led to the formation of YAP/P73 transcriptional
complex in HPMECs, as determined by immunoblotting with
antibodies against P-YAP (Y357) after immunoprecipitation
of P73 (Figures 4A,B). Meanwhile, Immunoblotting analysis
revealed that combination of LPS and CHX significantly induced
P73 expression (Figure 4C). After transfecting with YAP or
control siRNA for 6 h, the HPMECs were treated with medium,
LPS, CHX or the combination of LPS and CHX for 24 h.
We further found that YAP knockdown effectively down-
regulated the expression of P73 in HPMECs (Figure 4D). We
examined HPMECs transfected with P73 siRNA. The effect
of P73 knockdown was confirmed by Western blot analysis
(Figure 4E). The results showed that P73 depletion inhibited
LPS plus CHX-induced caspase-3 activation in HPMECs
(Figure 4F)
YAP/P73 Signaling Is Implicated in
LPS-Induced HPMEC Apoptosis via
Regulation of BAX and BCL-2 Expression
BCL-2 family proteins-mediated intrinsic apoptosis pathway
plays an important role in LPS-induced EC apoptosis (Wang
et al., 2007). We further determined the expression of the pro-
apoptotic protein BAX and the anti-apoptotic protein BCL-
2 during LPS plus CHX-induced HPMEC apoptosis. Western
blot analyses revealed that the combination of LPS and CHX
promoted BAX expression and inhibited BCL-2 expression in
HPMEC at the indicated times (Figures 5A,B). To determine the
role of YAP/P73 signaling on the expression of BAX and BCL-2
during HPMEC apoptosis, HPMECs were transfected with YAP
siRNA or P73 siRNA. The results showed that both YAP and P73
depletion reversed LPS and CHX-induced up-regulation of BAX
and down-regulation of BCL-2 (Figures 5C–F).
DISCUSSION
The hyper-permeability of the microvasculature complicates
sepsis (Gustot, 2011). Human endothelial cells undergo injury
and apoptosis resulting in detachment from the vessel wall
in patients with sepsis (Schlichting et al., 2011; Zahran et al.,
2016). Lung micro-vascular EC apoptosis-mediated vascular
hyper-permeability acts as an important initiator of ALI in
response to LPS (Damarla et al., 2014). However, the mechanism
underlying LPS-induced HPMEC apoptosis in vitro is not
well understood. In the present study, We showed that
YAP accelerated LPS-induced HPMEC apoptosis through its
phosphorylation activation and accumulation in EC nucleus.
The localization of YAP in the nucleus further promoted the
combination between YAP and its target transcription factor P73
to regulate the expression of BCL-2 and BAX. Our results found
that YAP, P73, BAX, BCL-2 and caspase-3 were implicated in
HPMEC apoptosis triggered by LPS plus CHX. These findings
showed that the YAP/P73/(BAX and BCL-2)/caspase-3 signaling
pathway was likely vital for mediating the development of lung
injury under sepsis.
Previous reports demonstrated that LPS alone could rapidly
induce apoptosis of human ECs in vitro (Kim et al., 2002;
Damarla et al., 2014). However, our study found that stimulating
HPMECs with LPS did not lead to cellular death. Instead,
LPS induced slight cell proliferation, potentially because human
endothelial cells incubated with LPS activate both pro-apoptotic
and also anti-apoptotic pathways in vitro (Bannerman et al., 2001,
2004).
FLICE-like inhibitor protein (FLIP) was known as the core
anti-apoptotic protein induced by LPS in human ECs. Shiga-
like toxin (SLT) and Shiga toxin, which are produced by Shigella
dysenteriae serotype 1 and certain strains of Escherichia coli,
have been clearly established to inhibit expression of FLIP and
sensitize ECs to LPS-induced apoptosis (Louise and Obrig, 1992;
Erwert et al., 2002). However, in the parallel studies between
micro-vascular ECs and macro-vascular ECs, the combination of
LPS and SLT only induced cytotoxicity in the macro-vascular-
derived human umbilical vein ECs, not in the micro-vascular
ECs (Obrig et al., 1993). Cycloheximide (CHX) is a nonspecific
inhibitor of protein synthesis. It also sensitizes human ECs
to LPS-induced apoptosis by both the rapid degradation of
preexisting FLIP and the inhibition of de novo synthesis of FLIP
molecules (Bannerman and Goldblum, 2003). Many previous
studies have reported that the micro-vascular ECs apoptosis
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FIGURE 2 | YAP is activated during LPS-induced HPMEC apoptosis. Expression of YAP and P-YAP (Y357) in HPMECs at the indicated time points after
stimulation with LPS (1µg/ml) and CHX (10µg/ml) (A,B). Cells treated with medium alone were used as the negative control. *P < 0.05 vs. the negative control group.
HPMECs were exposed to LPS (1µg/ml) and CHX (10µg/ml) before fixation and staining with anti-P-YAP (Y357) antibody as described in Materials and Methods (C).
P-YAP (Y357) (red) and nuclear staining with DAPI (blue) were visualized by immunofluorescence microscopy. Simultaneously, P-YAP (Y357) (brown) was detected by
immunocytochemistry after incubation with LPS (1µg/ml) and CHX (10 µg/ml). White arrows represent the expression of P-YAP (357) in the nucleus in HPMECs.
model in vitro mainly induced by the stimulation of LPS plus
CHX (Choi et al., 1998; Wang et al., 2007; Karahashi et al.,
2009). In the study, we further explored the mechanism of LPS-
induced human pulmonary micro-vascular ECs in the presence
of CHX.
Some previous studies have observed that CHX (40µg/ml)
can sensitize LPS-induced human ECs apoptosis in vitro
(Bannerman et al., 2004; Karahashi et al., 2009). Consistent
with the previous study, we also found that LPS induced a
remarkably decreased rate of survival and increased rate of
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FIGURE 3 | YAP protein accelerates LPS-induced HPMEC apoptosis. Western blot analysis of YAP depletion in HPMECs (A,B). #P < 0.05 vs. the control
siRNA group. After transfection with YAP siRNA or control siRNA for 6 h, HPMECs were treated with LPS (1µg/ml) and CHX (10µg/ml) for the indicated times, and
apoptotic cells was detected by Annexin V/PI staining (C). The percentage of total apoptotic cells and early apoptotic cells are presented as a histogram showing
results obtained by flow cytometry (D,E). *P < 0.05 vs. the control group. #P < 0.05 vs. the corresponding LPS and CHX treatment group. HPMECs were transfected
with YAP siRNA or control siRNA for 6 h and then stimulated with medium alone, LPS, CHX, or the combination of LPS and CHX for 24 h. The levels of cleaved PARP
were determined by Western blot analysis (F). The Western blotting results are presented as a histogram showing the band intensity values (G). Cells treated with
medium alone were used as the negative control. *P < 0.05 vs. the negative control group. #P < 0.05 vs. the corresponding LPS and CHX treatment groups.
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FIGURE 4 | YAP interacts with P73 during LPS-induced HPMEC apoptosis. P73 and phosphor-YAP (Y357) formed the signaling complex. Co-IP was
performed to detect the P73-YAP complex at the indicated times after stimulation with LPS and CHX. Western blotting was performed to detect P-YAP (Y357) in the
IP complexes (A). The expression of phosphor-YAP (Y357) in IP complexes is presented as a histogram showing the band intensity values (B). *P < 0.05 vs. the
untreated group. HPMECs were incubated with LPS (1µg/ml) and CHX (10µg/ml) for 24 h, and P73 protein was detected by Western blot analysis (C). *P < 0.05 vs.
the control group. HPMECs were transferred with YAP siRNA or control siRNA for 6 h and then stimulated with medium alone, LPS, CHX, or the combination of LPS
and CHX for 24 h. The levels of P73 were determined by Western blot analysis (D). Cells treated with medium alone were used as the negative control. *P < 0.05 vs.
the negative control group. #P < 0.05 vs. the corresponding LPS and CHX treatment group. Western blot analysis of P73 depletion in HPMECs (E). #P < 0.05 vs.
the control siRNA group. After transfection with P73 siRNA or control siRNA for 6 h, HPMECs were treated with LPS (1µg/ml) and CHX (10µg/ml) for the indicated
times, and cleaved caspase-3 was detected by Western blot analysis (F). Cells treated with medium alone were used as the negative control. *P < 0.05 vs. the
negative control group. #P < 0.05 vs. the corresponding LPS and CHX treatment group.
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FIGURE 5 | YAP/P73 signaling is involved in LPS-induced HPMEC apoptosis via regulation of BAX and BCL-2. The HPMECs were exposed to the
combination of LPS (1µg/ml) and CHX (10µg/ml) for 24 h, and BAX and BCL-2 expression levels were measured by Western blot analysis (A,B). After transfection
with YAP siRNA or control siRNA, HPMECs were treated with LPS (1µg/ml) and CHX (10µg/ml) for the indicated times, and BAX and BCL-2 were detected by
Western blot analysis (C). The Western blotting results are presented as a histogram showing the band intensity values (D). Cells treated with medium alone were
used as the negative control. *P < 0.05 vs. the negative control group. #P < 0.05 vs. the corresponding LPS and CHX treatment group. HPMECs were transfected
with P73 siRNA or control siRNA for 6 h and were then stimulated with medium alone, LPS, CHX, or the combination of LPS and CHX for 24 h. The levels of BAX and
BCL-2 protein were determined by Western blot analysis (E). The Western blotting results are presented as a histogram showing the band intensity values (F). Cells
treated with medium alone were used as the negative control. *P < 0.05 vs. the negative control group. #P < 0.05 vs. the corresponding LPS and CHX treatment
groups.
apoptosis in HPMECs in the presence of lower concentration of
CHX (10µg/ml). In order to find out the optimal concentration
of LPS in the study of HPMECs apoptosis in vitro, we further
used different concentrations of LPS (0, 0.01, 0.1, 1, 10, and
100 µg/ml) to incubate primary HPMECs under the presence of
CHX (10µg/ml). We found that the peak of total apoptosis rate
and early apoptosis rate of HPMECs appeared at concentrations
of 1µg/ml. Though these observations are analogous to previous
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reports in which authors showed that LPS (0.1µg/ml) plus CHX
(50 µg/ml) activated a FADD-dependent apoptotic pathway in
the human dermal micro-vascular cell line (HMEC-1) (Choi
et al., 1998), the optimal concentration of LPS (1µg/ml) in
our study is 10 times higher than the previous reports. The
reasons may be that the primary HPMECs is more sensitive to
the stimulation of CHX and need higher concentration of LPS
when the stimulating concentration of CHX (10µg/ml) is low.
In addition, because primary HPMECs are sensitive to the lack
of endothelial cell growth supplement and fetal bovine serum
in the endothelial cell medium, we used complete medium plus
LPS and/or CHX to study HPMECs apoptosis in vitro. The anti-
apoptosis roles of endothelial cell growth supplement and fetal
bovine serum may counteract the pro-apoptosis roles of LPS in
the physiological concentration. Therefore, it may be the reasons
that HPMECs apoptosis is induced with high concentration of
LPS (1µg/ml) in our study.
YAP is a crucial transcriptional co-activator shuttling between
nucleus and cytoplasm and its activity is tightly regulated by
several upstream kinases (Yagi et al., 1999). YAP phosphorylation
on serine 127 by Akt increases the interaction of YAP with
the cytosolic 14-3-3 protein leading to inactivation of YAP and
subsequent YAP degradation in cytoplasm (Basu et al., 2003).
On the contrary, c-Abl phosphorylates YAP on tyrosine 357
results in activation of YAP, which is implicated in promoting
cancer cells apoptosis (Levy et al., 2008; Jie et al., 2013). In our
study, we demonstrated for the first time that YAP protein was
activated in HPMECs during LPS and CHX-induced HPMEC
apoptosis. In addition, we also showed that the activated YAP
accumulated in HPMEC nucleus after stimulation with LPS and
CHX. Importantly, we found that knockdown of YAP protein
attenuated the apoptosis induced by LPS plus CHX. Thus, above
results revealed that YAP protein was required for LPS and CHX-
induced HPMEC apoptosis and that apoptosis was associated
with nuclear accumulation of activated YAP.
As a transcriptional co-activator, YAP protein needs to
bind target transcription factors to stimulate downstream gene
expression (Li et al., 2010). Previous studies have showed
that YAP protein positively regulates transcription factor P73
and Egr-1 in promoting cellular apoptosis through mediating
the expression of death-associated genes (Lapi et al., 2008;
Zagurovskaya et al., 2009). Interestingly, YAP activation by
phosphorylation on T357 displays higher affinity to P73
(Levy et al., 2008). Our study found that the combination
of LPS and CHX induced augment and nuclear localization
of P-YAP (T357) in HPMECs. However, whether P-YAP
(T357) interacts with P73 during LPS plus CHX-induced EC
apoptosis is unclear. Here, we showed that the interaction
between P-YAP (T357) and P73 increased in HPMECs after
treatment of LPS and CHX. This result supported the idea
that YAP protein may be involved in LPS plus CHX-induced
HPMEC apoptosis via the formation of YAP/P73 transcriptional
complex. We also found that stimulation of LPS and CHX
promoted the augment of P73 protein. In addition, knockdown
of YAP effectively inhibited LPS plus CHX-induced P73
expression. These results may be due to the reason that YAP
competes with ITCH to bind P73, which inhibits degradation
of P73 and selectively co-activates P73 (Levy et al., 2007).
Moreover, knockdown of P73 also inhibited the LPS plus CHX-
induced caspase-3 activation in HPMECs. Therefore, our results
indicated that the formation of YAP/P73 transcriptional complex
was crucial for mediating LPS plus CHX-induced HPMEC
apoptosis.
BAX and BCL-2 are the transcriptional target proteins of
P73 (Tiwary et al., 2011). BAX and BCL-2 activate caspases by
promoting the release of cytochrome C from mitochondrion
(Adrain and Martin, 2001). Studies have proved that the
BAX expression of lung is increased and BCL-2 expression
of lung is decreased in sepsis-induced ALI model in mice
(Chopra et al., 2009). Analogous to previous reports, we also
observed BAX up-regulation and BCL-2 down-regulation in
LPS plus CHX-incubated HPMECs, which coincided with the
augment in YAP phosphorylation and P73 activation during
LPS plus CHX-induced HPMEC apoptosis. However, whether
YAP/P73 signaling pathway mediates the regulation of BAX
and BCL-2 expression in LPS plus CHX-induced HPMEC
apoptosis is still unknown. In the present study, inhibition
of YAP/P73 signaling by siRNA reversed LPS plus CHX-
induced up-regulation of BAX and down-regulation of BCL-
2. The above observations are consistent with previous reports
in which authors demonstrated that YAP or P73 respectively
contributed to regulate the expression of BAX and BCL-2 in the
process of different cancer cell apoptosis (Melino et al., 2004;
Chipuk and Green, 2009; Xu et al., 2015). Taken together, our
data suggested that YAP protein accelerated LPS plus CHX-
induced HPMEC apoptosis via interaction with transcription
factor P73, leading to caspase-3 activation through the up-
regulation of BAX expression and down-regulation of BCL-2
expression. However, although CHX have been used as tool
to promote sensitization to LPS-induced HPMECs apoptosis
in vitro, it is unlikely that LPS and CHX co-exist in human
body. So, the LPS plus CHX-induced HPMECs apoptosis model
in vivo is constrained. Interestingly, SLT is a more clinically
relevant type of protein synthesis inhibitor induced by bacteria,
and micro-vascular ECs are a principal target of SLT-1 in
vivo (O’Loughlin and Robins-Browne, 2001). Escherichia coli
produce SLT-1 in addition to LPS. In this regard, whether
YAP signaling involved in LPS plus SLT-1-induced HPMECs
apoptosis and sepsis-associated ALI in vivo need to be studied
further.
In conclusion, we demonstrated that YAP mediated LPS-
induced HPMEC apoptosis in vitro via its phosphorylation
activation and accumulating in nucleus to bind its target
transcription factor P73 to stimulate BAX expression and
inhibit BCL-2 expression. Our results raised the possibility
that YAP/P73/(BAX and BCL-2)/caspase-3 pathway played an
important role in regulating HPMEC apoptosis in sepsis-induced
ALI.
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